Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
04/2007
04/12/2007WO2006134163A3 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
04/12/2007US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
04/12/2007US20070082909 Acyclic Ikur inhibitors
04/12/2007US20070082896 4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(4-carboxybutoxy)pyrimidin-2-yl]}amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; cholesteryl ester transfer protein (CETP) inhibitors; increasing HDL cholesterol; lowering LDL cholesterol; arteriosclerosis, hyperlipidemia
04/12/2007US20070082883 HIV protease inhibitors
04/12/2007CA2625340A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same
04/12/2007CA2624378A1 Macroheterocylic compounds as kinase inhibitors
04/12/2007CA2623715A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
04/12/2007CA2623154A1 Novel fused pyrrole derivative
04/12/2007CA2623114A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
04/12/2007CA2623058A1 Pyrimidine compounds for the treatment of inflammatory disorders
04/11/2007EP1771453A1 Hepatitis c inhibitor dipeptide analogs
04/11/2007EP1771450A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/11/2007EP1771436A1 Kynurenic acid amide derivatives as nr2b receptor antagonists
04/11/2007EP1771434A2 Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives
04/11/2007EP1414458B1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
04/11/2007EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
04/11/2007EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents
04/11/2007CN1946852A Labeling of rapamycin using rapamycin-specific methylases
04/11/2007CN1946720A Azabenzofuran substituted thioureas; inhibitors of viral replication
04/11/2007CN1946690A Cyclobutenedione groups-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
04/11/2007CN1944431A 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative
04/11/2007CN1309722C Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
04/11/2007CN1309709C C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
04/10/2007US7202363 Thienopyridine and furopyridine kinase inhibitors
04/10/2007US7202361 Antitumoral ecteinascidin derivatives
04/10/2007US7202264 Supports for oligomer synthesis
04/10/2007US7202256 Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779
04/10/2007US7202255 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same
04/10/2007US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity
04/05/2007WO2007038138A2 Amido compounds and their use as pharmaceuticals
04/05/2007WO2007037742A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia
04/05/2007WO2006089406A8 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
04/05/2007US20070078156 Derivatives of n-(1h-indazolyl)-and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for treatment of pain
04/05/2007US20070078132 tyrosine kinase inhibitors such as 7H,19H-4,6-ethanediylidenepyrimido[4,5-b][13,1,4,6]benzoxatriazacyclopentadecine, 17-chloro-8,9,10,11,12,13-hexahydro, used for treating hyper proliferative disorders such as atherosclerosis, restenosis and cancer
04/05/2007US20070078124 1-Aza-2-oxa-dibenzo(e,h)azulenes and their use for the treatment of central nervous system diseases and disorders
04/05/2007CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
04/05/2007CA2621255A1 Amido compounds and their use as pharmaceuticals
04/04/2007EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/04/2007CN1942476A Regiospecific synthesis of rapamycin 42-ester derivatives
04/04/2007CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
04/04/2007CN1939307A 2,4,6-triamino-1,3,5-triazine derivative
04/04/2007CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
04/04/2007CN1308311C Novel pyridine- and quinoline-derivatives
04/04/2007CN1308310C Nitrogenous aromatic ring compounds
04/03/2007US7199146 Imidazolidinedione analogs useful as anticoagulants and antithrombotics
04/03/2007US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists
04/03/2007US7199119 Antiinflammation agents
04/03/2007CA2281918C Oxazolidines as 5-ht2a-antagonists
03/2007
03/29/2007WO2007035709A2 Novel crystal forms of irinotecan hydrochloride
03/29/2007WO2006136552A3 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
03/29/2007WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists
03/29/2007WO2005110410A3 Kinase inhibitors as therapeutic agents
03/29/2007US20070072924 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
03/29/2007US20070072890 Novel crystal forms of irinotecan hydrochloride
03/29/2007US20070072888 Indol-3-yl-carbonyl-azaspiro derivatives
03/29/2007US20070072887 Spirofuropyridine aryl derivatives
03/29/2007US20070072865 Bicyclic piperazine compound and use thereof
03/29/2007US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
03/29/2007US20070072832 4-(2-Amino-5-chloro-benzoimidazol-1-yl)-2,2-dimethyl-2H-chromene-6-carbonitrile; urinary incontinence, hypertension, sexual disorders, dysmenorrhea, irritable bowl syndrome, airway hyperactivity, epilepsy, Alzheimer's and Parkinson's diseases, myocardial injury, coronary artery disease, hair loss
03/29/2007US20070072254 Reacting 4-methyl-5-alkoxy-oxazole with substituted dihydro-(1,3)-dioxepin compound, in absence of solvent and catalyst to give product mixture consisting of Diels-Alder adducts; distillation; hydrolysis; deblocking, deprotecting; deacylation
03/28/2007EP1767537A1 Pyrimidine compounds for the treatment of inflammatory disorders
03/28/2007EP1765829A1 Tricyclic compounds and their use as mglur1 antagonists
03/28/2007EP1765330A2 Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
03/28/2007CN1938388A Reversible piezochromic systems
03/28/2007CN1938315A Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same
03/28/2007CN1938314A Tetrahydroquinoline derivatives and a process for preparing the same
03/28/2007CN1938299A Thioamide derivatives as progesterone receptor modulators
03/28/2007CN1938298A Methods for minimizing thioamide impurities
03/28/2007CN1938283A Pyridazinones as antagonists of alpha4 integrins
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/28/2007CN1307180C Method for extracting galanthamine from raw materials of genera of lycoris radiata or snowdrop
03/28/2007CN1307178C Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists
03/28/2007CN1307155C Deltal-pyrrolines used as pesticides
03/27/2007US7196199 Phenoxypropylamine compounds
03/27/2007US7196110 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196096 Substituted amines of spirofuropyridines useful in therapy
03/27/2007US7196076 Androgen receptor modulators and methods of use thereof
03/27/2007CA2326611C Substituted heterocyclic derivatives
03/22/2007US20070066674 Tricyclic imidzopyridines for use as gastric secretion inhibitors
03/22/2007US20070066671 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
03/22/2007US20070066630 nicotinic acid receptor agonists comprising pyrano[2,3-d]pyrimidine derivatives, useful for treating metabolic syndrome, dyslipidemia, diabetes, nervous system disorders, cancer, inflammation, cardiovascular, respiratory, gastroenterological, hematological and fatty liver disease
03/22/2007US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases
03/22/2007US20070066608 Novel indole derivatives with an improved antipsychotic activity
03/22/2007US20070066577 Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
03/22/2007US20070066575 Methods and compositions for mitigating pain
03/21/2007EP1425282B1 Process for the preparation of diketopyrrolopyrroles
03/21/2007EP1345943B1 Inhibitors of papilloma virus
03/21/2007CN1934116A Tricyclic benzopyran compound as anti-arrhythmic agents
03/21/2007CN1934105A Aryl-substituted heterocycles, process for their preparation and their use as medicaments
03/21/2007CN1934094A Diaryl-substituted five-membered heterocycle derivative
03/21/2007CN1931859A New fused imidazole derivative
03/21/2007CN1931827A 2- and 2,5-substituted phenylketo-enols
03/21/2007CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands
03/21/2007CN1305860C Condensed quinazoline derirative used as tyrosine kinase inhibitor
03/20/2007US7193080 Color photography
03/20/2007CA2297326C Heterocyclic compound and antitumor agent containing the same as active component
03/15/2007WO2007029106A1 Isoquinolines as igf-1r inhibitors
03/15/2007WO2007029037A2 Class iia histone deacetylase (hdac) substrate